BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/19/2024 8:45:27 AM | Browse: 153 | Download: 718
 |
Received |
|
2024-02-02 15:18 |
 |
Peer-Review Started |
|
2024-02-02 15:18 |
 |
First Decision by Editorial Office Director |
|
2024-02-29 20:09 |
 |
Return for Revision |
|
2024-02-29 20:09 |
 |
Revised |
|
2024-03-07 13:01 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-04-02 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-04-02 02:50 |
 |
Articles in Press |
|
2024-04-02 02:50 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-15 05:49 |
 |
Publish the Manuscript Online |
|
2024-04-19 08:45 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Circulating tumor DNA in liquid biopsy: Current diagnostic limitation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shi-Cai Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Talent Scientific Research Start-up Foundation of Wannan Medical College |
WYRCQD2023045 |
|
| Corresponding Author |
Shi-Cai Liu, PhD, Academic Research, School of Medical Information, Wannan Medical College, No. 22 Wenchang West Road, Wuhu 241002, Anhui Province, China. liushicainj@163.com |
| Key Words |
Cell-free DNA; Circulating tumor DNA; Liquid biopsy; Cancer; Diagnosis; Prognosis |
| Core Tip |
Tumor liquid biopsy based on cell-free DNA detection has become a major hotspot in the field of tumor research in recent years. Circulating tumor DNA (ctDNA) is a DNA fragment that breaks down from cells in primary tumors or even new tumors formed by metastasis, and enters the peripheral circulation. ctDNA analysis provides a non-invasive method for cancer detection and monitoring, which is important for the management of clinical patients. |
| Publish Date |
2024-04-19 08:45 |
| Citation |
Liu SC. Circulating tumor DNA in liquid biopsy: Current diagnostic limitation. World J Gastroenterol 2024; 30 (15): 2175-2178 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i15/2175.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i15.2175 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.